The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small ...
Caplacizumab is a von Willebrand factor (vWF)-directed antibody fragment designed to inhibit the interaction between vWF and platelets.
Staying on top of your health isn’t just about hitting the gym, eating well, or getting the necessary vaccines. It also means ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback